Natural Killer T cell - Globe Thesis

Keyword [Natural Killer T cell] Result: 21 - 40 \| Page: 2 of 3
21.	K562 Feeder Cells Promote The Expansion And Cytotoxicity Of INKT Cells
22.	One Case Report About Primary Plumomary Natural Killer/T-cell Lymphoma Presenting As Masses And Cavites And Review Of The Literature
23.	Expression Of Regulatory T Cells And Natural Killer T Cells In Peripheral Blood Of Children With Wilms Tumor
24.	Application Of ¹⁸F-FDG PET/CT In The Diagnosis And Staging Of Extranodular Natural Killer/T-cell Lymphoma Nasal Type
25.	The Clinical Features And Survival Prognosis Analysis Of Non-upperaerodigestive Tract Extranodal Natural Killer/T-cell Lymphoma
26.	The Correlation Analysis Of The Reactive Splenomegaly And The Curative Effect And Prognosis In The Extranodal NK/T Cell Lymphoma
27.	Comparison Of Efficacy And Analysis Of Prognosis Of Radiotherapy Alone,PGEMOX Regimen Sequential Radiotherapy,and PGEMOX Regimen Sandwich Radiotherapy Treatment For Early Stage Extranodal Natural Killer/T Cell Lymphoma
28.	Treatment And Prognosis For Diffuse Large B-cell Lymphoma And NK/T-cell Lymphoma
29.	Functional Roles And Mechanisms Of PABPC1 In The Development And Progression Of Natural Killer/T-cell Lymphoma
30.	Synthesis And Immunological Evaluation Of Anti-Cancer Carbohydrate Vaccine Covalently Conjugating With Agonist Of Natural Killer T Cell (KRN7000)
31.	The Correlation Study Between Natural Killer Cell And Natural Killer T Cell And Cytokine With Unexplained Recurrent Spontaneous Abortion In Peripheral Blood
32.	IL-13 Promotes Cell Proliferation In Extranodal Natural Killer/T Cell Lymphoma
33.	Aquaporin 3 Facilitates Chemoresistance In Extranodal Natural Killer/T Cell Lymphoma To Gemcitabine
34.	The Effect Of TIM-3 Ligand Galectin-9 On The Apoptosis Of Natural Killer/T Cell Lymphoma Cells
35.	Changes And Clinical Significance Of Invariant Natural Killer T Cells And Their Subsets In Newly Diagnosed Type 1 Diabetic Patients
36.	The Clinical Study Of Concurrent Chemoradiotherapy For Extranodal Natural Killer/t-cell Lymphoma Nasal Type In Localized Stages
37.	The Expression And Prognostic Value Of PD-1,TIM-3,LAG-3 And BTLA In Extranodal NK/T Cell Lymphoma
38.	Mechanisms that regulate natural killer T cell autoreactivity
39.	Research on Natural Killer T cell ligands and the therapeutic application
40.	Overcoming Graft-vs.-Host Disease in the Humanized Mouse and Using Natural Killer T cell Activation as an Adjuvant in an Epstein-Barr Virus Vaccine
<<First <Prev Next> Last>> Jump to